{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:10:12Z","timestamp":1764259812936},"reference-count":39,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.3892\/or.2013.2301","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T09:43:35Z","timestamp":1361526215000},"page":"2065-2071","source":"Crossref","is-referenced-by-count":7,"title":["Promising anti-leukemic activity of atorvastatin"],"prefix":"10.3892","volume":"29","author":[{"given":"JOLANTA D.","family":"\u017bO\u0141NIERCZYK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARLETA","family":"BOROWIAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAWE\u0141","family":"HIKISZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BARBARA","family":"CEBULA-OBRZUT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JERZY Z.","family":"B\u0141O\u0143SKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PIOTR","family":"SMOLEWSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TADEUSZ","family":"ROBAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZOFIA M.","family":"KILIA\u0143SKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,2,22]]},"reference":[{"issue":"Suppl 6","key":"key20180107214202_b1-or-29-05-2065","doi-asserted-by":"crossref","first-page":"vi50","DOI":"10.1093\/annonc\/mdr377","article-title":"Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Eichhorst","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180107214202_b2-or-29-05-2065","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2007-12-129379","article-title":"Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century","volume":"111","author":"Brenner","year":"2008","journal-title":"Blood"},{"key":"key20180107214202_b3-or-29-05-2065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/187152010794479799","article-title":"Potential new agents for chronic lymphocytic leukemia treatment","volume":"10","author":"Kilia\u0144ska","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107214202_b4-or-29-05-2065","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"key20180107214202_b5-or-29-05-2065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2002-01-0189","article-title":"Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin","volume":"101","author":"Decker","year":"2003","journal-title":"Blood"},{"key":"key20180107214202_b6-or-29-05-2065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"key20180107214202_b7-or-29-05-2065","first-page":"542","article-title":"Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins","volume":"1","author":"Roy","year":"2011","journal-title":"Am J Cancer Res"},{"key":"key20180107214202_b8-or-29-05-2065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0301-472X(03)00192-9","article-title":"Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9","volume":"31","author":"Chapman-Shimshoni","year":"2003","journal-title":"Exp Hematol"},{"key":"key20180107214202_b9-or-29-05-2065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"key20180107214202_b10-or-29-05-2065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2011.05.016","article-title":"Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts","volume":"255","author":"Copajaa","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20180107214202_b11-or-29-05-2065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.leu.2402476","article-title":"HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis","volume":"16","author":"Wong","year":"2002","journal-title":"Leukemia"},{"key":"key20180107214202_b12-or-29-05-2065","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107214202_b13-or-29-05-2065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/carcin\/23.3.521","article-title":"Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells","volume":"23","author":"Agarwal","year":"2002","journal-title":"Carcinogenesis"},{"key":"key20180107214202_b14-or-29-05-2065","first-page":"5735","article-title":"Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells","volume":"9","author":"van de Donk","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107214202_b15-or-29-05-2065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejca.2004.12.009","article-title":"The potential of statins as part of anti-cancer treatment","volume":"41","author":"Sleiffer","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107214202_b16-or-29-05-2065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200519935","article-title":"Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts","volume":"115","author":"Zhuang","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180107214202_b17-or-29-05-2065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"key20180107214202_b18-or-29-05-2065","first-page":"1389","article-title":"In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and\/or mitoxantrone","volume":"16","author":"Kobylinska","year":"2006","journal-title":"Oncol Rep"},{"key":"key20180107214202_b19-or-29-05-2065","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood.V94.8.2836.420k35_2836_2843","article-title":"In vitro evaluation of fludarabine in combination with cyclophosphamide and\/or mitoxantrone in B-cell chronic lymphocytic leukemia","volume":"94","author":"Bellosillo","year":"1998","journal-title":"Blood"},{"key":"key20180107214202_b20-or-29-05-2065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"key20180107214202_b21-or-29-05-2065","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107214202_b22-or-29-05-2065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cyto.a.20357","article-title":"Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete \u2018sub-G1\u2019 peaks on DNA content histograms","volume":"71","author":"Kajstura","year":"2007","journal-title":"Cytometry A"},{"key":"key20180107214202_b23-or-29-05-2065","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/sj.onc.1204008","article-title":"Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint","volume":"19","author":"Kim","year":"2000","journal-title":"Oncogene"},{"key":"key20180107214202_b24-or-29-05-2065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00277-010-0988-z","article-title":"Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells","volume":"89","author":"Podhorecka","year":"2010","journal-title":"Ann Hematol"},{"key":"key20180107214202_b25-or-29-05-2065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1101\/gad.1093903","article-title":"Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation","volume":"17","author":"Nijhawan","year":"2003","journal-title":"Genes Dev"},{"key":"key20180107214202_b26-or-29-05-2065","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/10428190410001723317","article-title":"Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia","volume":"45","author":"Johnston","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"key20180107214202_b27-or-29-05-2065","first-page":"699","article-title":"Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells","volume":"11","author":"Kobylinska","year":"2004","journal-title":"Oncol Rep"},{"key":"key20180107214202_b28-or-29-05-2065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajh.10453","article-title":"Mcl-1 and Bcl-2\/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia","volume":"75","author":"Saxena","year":"2004","journal-title":"Am J Hematol"},{"key":"key20180107214202_b29-or-29-05-2065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","article-title":"Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy","volume":"112","author":"Muzio","year":"2008","journal-title":"Blood"},{"key":"key20180107214202_b30-or-29-05-2065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejca.2009.11.023","article-title":"Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia","volume":"46","author":"Grzybowska-Izydorczyk","year":"2010","journal-title":"Eur J Cancer"},{"key":"key20180107214202_b31-or-29-05-2065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopha.2007.07.007","article-title":"Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro","volume":"62","author":"Salman","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"key20180107214202_b32-or-29-05-2065","doi-asserted-by":"crossref","first-page":"22398","DOI":"10.1074\/jbc.271.37.22398","article-title":"Calcium-dependent, interleukin 1-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei","volume":"271","author":"McConkey","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107214202_b33-or-29-05-2065","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1523\/JNEUROSCI.23-22-07967.2003","article-title":"Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1","volume":"23","author":"Garnier","year":"2003","journal-title":"J Neurosci"},{"key":"key20180107214202_b34-or-29-05-2065","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1182\/blood.V91.12.4694","article-title":"Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia","volume":"91","author":"Vrhovac","year":"1998","journal-title":"Blood"},{"key":"key20180107214202_b35-or-29-05-2065","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1038\/sj.onc.1202860","article-title":"Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity","volume":"18","author":"Eymin","year":"1999","journal-title":"Oncogene"},{"key":"key20180107214202_b36-or-29-05-2065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1749-6632.2009.04903.x","article-title":"Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide","volume":"1171","author":"Zolnierczyk","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"key20180107214202_b37-or-29-05-2065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0161-5890(02)00252-3","article-title":"The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions","volume":"39","author":"Borner","year":"2003","journal-title":"Mol Immunol"},{"key":"key20180107214202_b38-or-29-05-2065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.leukres.2006.06.027","article-title":"Larger than life: mitochondria and the Bcl-2 family","volume":"31","author":"Skommer","year":"2007","journal-title":"Leuk Res"},{"key":"key20180107214202_b39-or-29-05-2065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.04.011","article-title":"Statin and cancer: current and future prospects","volume":"324","author":"Osmak","year":"2012","journal-title":"Cancer Lett"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2301\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T07:41:48Z","timestamp":1644392508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,22]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,2,22]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.3892\/or.2013.2301"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2301","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,22]]}}}